Sign Up Today and Learn More About BioAge Labs Stock
Invest in or calculate the value of your shares in BioAge Labs or other pre-IPO companies through EquityZen's platform.
BioAge Labs Stock (BILB)
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
About BioAge Labs Stock
Founded
2015
Headquarters
Richmond, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
BioAge Labs Press Mentions
Stay in the know about the latest news on BioAge Labs
Jefferies starts BioAge Labs with 'buy' on novel obesity drug
tradingview • Oct 21, 2024
Wall Street analysts initiate coverage of BioAge Labs
investing • Oct 21, 2024
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
fool • Oct 06, 2024
North American Startup Funding Weakened In Q3 As Largest Deal Took Longer To Close
news • Oct 04, 2024
BioAge Labs Announces Pricing of Upsized Initial Public Offering
globenewswire • Sep 26, 2024
BioAge Labs Management
Leadership team at BioAge Labs
CEO & Co-Founder
Kristen Fortney
Co-founder and COO
Eric Morgen
Join now and verify your accreditation status to gain access to:
- BioAge Labs current valuation
- BioAge Labs stock price
- Available deals in BioAge Labs and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in BioAge Labs stock?
Accredited investors can buy pre-IPO stock in companies like BioAge Labs through EquityZen funds. These investments are made available by existing BioAge Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioAge Labs stock?
Shareholders can sell their BioAge Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
